Production (Stage)
Dynavax Technologies Corporation
DVAX
$10.27
-$0.13-1.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 285.55M | 268.43M | 248.46M | 231.44M | 217.69M |
| Total Other Revenue | 9.08M | 8.82M | 12.35M | 18.26M | 18.46M |
| Total Revenue | 294.62M | 277.25M | 260.81M | 249.70M | 236.15M |
| Cost of Revenue | 117.01M | 108.26M | 98.88M | 98.80M | 98.47M |
| Gross Profit | 177.61M | 168.99M | 161.94M | 150.90M | 137.68M |
| SG&A Expenses | 178.75M | 168.10M | 168.11M | 163.25M | 158.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 295.76M | 276.35M | 266.99M | 262.05M | 257.32M |
| Operating Income | -1.14M | 893.00K | -6.18M | -12.36M | -21.17M |
| Income Before Tax | -55.52M | 30.86M | 24.22M | 18.55M | 7.85M |
| Income Tax Expenses | 4.55M | 3.55M | 3.75M | 1.37M | -1.37M |
| Earnings from Continuing Operations | -60.07 | 27.31 | 20.48 | 17.18 | 9.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.07M | 27.31M | 20.48M | 17.18M | 9.22M |
| EBIT | -1.14M | 893.00K | -6.18M | -12.36M | -21.17M |
| EBITDA | 3.54M | 5.52M | -1.62M | -7.87M | -16.72M |
| EPS Basic | -0.49 | 0.21 | 0.16 | 0.13 | 0.07 |
| Normalized Basic EPS | 0.12 | 0.15 | 0.12 | 0.08 | 0.03 |
| EPS Diluted | -0.52 | 0.18 | 0.13 | 0.11 | 0.06 |
| Normalized Diluted EPS | 0.09 | 0.12 | 0.09 | 0.06 | 0.02 |
| Average Basic Shares Outstanding | 514.87M | 520.20M | 521.63M | 519.49M | 517.19M |
| Average Diluted Shares Outstanding | 587.17M | 592.50M | 572.75M | 572.14M | 569.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |